{
    "Rank": 905,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT03627988",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "18 SEIN 11"
                },
                "Organization": {
                    "OrgFullName": "Institut Claudius Regaud",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.",
                "OfficialTitle": "Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.",
                "Acronym": "MARTA"
            },
            "StatusModule": {
                "StatusVerifiedDate": "June 2023",
                "OverallStatus": "Active, not recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "June 7, 2019",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "May 2026",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "May 2026",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "August 2, 2018",
                "StudyFirstSubmitQCDate": "August 8, 2018",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "August 14, 2018",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "June 12, 2023",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "June 13, 2023",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Institut Claudius Regaud",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "Prospective, multicentric, non-randomized phase II study evaluating the surgical treatment by mastectomy with immediate prosthetic breast reconstruction in patients with breast cancer and receiving adjuvant therapy by TomoTherapy +/-Chemotherapy.\n\nPatients with non-inflammatory and non-metastatic invasive mammary carcinoma will be included in this study.\n\nThe study procedure will be a surgical treatment by mastectomy with immediate prosthetic breast reconstruction followed by an adjuvant therapy: TomoTherapy +/-Chemotherapy (radiation therapy alone or preceded by chemotherapy).\n\nThe nature of the chemotherapy treatment will be decided according to the standards of each center.\n\nThe patients will be followed for the study up to 36 months after the surgical procedure."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Cancer Invasive"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Breast Cancer Invasive",
                        "TomoTherapy",
                        "Immediate prosthetic breast reconstruction"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 2"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "N/A",
                    "DesignInterventionModel": "Single Group Assignment",
                    "DesignPrimaryPurpose": "Other",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "65",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Patients with breast cancer",
                            "ArmGroupType": "Experimental",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: Patients with invasive breast cancer will receive:"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Patients with invasive breast cancer will receive:",
                            "InterventionDescription": "Mastectomy with Immediate prosthetic breast reconstruction\nAdjuvant therapy by TomoTherapy (radiation therapy alone or preceded by chemotherapy).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Patients with breast cancer"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Rate of patients with successful mastectomy strategy by immediate reconstruction.",
                            "PrimaryOutcomeTimeFrame": "12 months for each patient"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Quality of the radiotherapy treatment plan (dosimetry).",
                            "SecondaryOutcomeTimeFrame": "78 months for all patients"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Progression-free survival.",
                            "SecondaryOutcomeTimeFrame": "36 months for each patient"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Early complications assessed using the National Cancer Institute Common Toxicity Criteria for Adverse Effects (NCI-CTCAE) version 4.03.",
                            "SecondaryOutcomeTimeFrame": "36 months for each patient"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Late complications assessed using the National Cancer Institute Common Toxicity Criteria for Adverse Effects (NCI-CTCAE) version 4.03.",
                            "SecondaryOutcomeTimeFrame": "36 months for each patient"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Quality of Life assessed using the questionnaire called \"Breast-Q\".",
                            "SecondaryOutcomeTimeFrame": "36 months for each patient"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Cosmetic outcome of treated breast assessed using a questionnaire with a Likert scale.",
                            "SecondaryOutcomeTimeFrame": "36 months for each patient"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nAge \u2265 18 years.\nPatient with a non-inflammatory and non-metastatic invasive mammary carcinoma.\nIndication of mastectomy and immediate prosthetic breast reconstruction.\nPatient wishing to have an immediate mammary reconstruction with prosthesis.\nFormal or presumptive pre-operative indication for adjuvant radiotherapy (+/- chemotherapy).\nOMS \u2264 2.\nPatient affiliated to a Social Health Insurance in France.\nPatient must provide written informed consent prior to any study specific procedures.\n\nExclusion Criteria:\n\nMetastatic breast cancer.\nBilateral breast cancer.\nInflammatory breast cancer (T4d).\nHistory of breast cancer within 5 years.\nNot applicable according to the protocol version N\u00b06 : Previous neoadjuvant treatment for the ongoing disease.\nPregnant or breastfeeding women.\nAny psychological, familial, geographical or sociological condition which does not allow to respect the medical follow-up and/or compliance to study procedure.\nPatient protected by law.",
                "HealthyVolunteers": "No",
                "Gender": "Female",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Institut Bergonie",
                            "LocationCity": "Bordeaux",
                            "LocationCountry": "France"
                        },
                        {
                            "LocationFacility": "Institut Universitaire Du Cancer de Toulouse - Oncopole",
                            "LocationCity": "Toulouse",
                            "LocationZip": "31059",
                            "LocationCountry": "France"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000001941",
                            "ConditionAncestorTerm": "Breast Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}